Mace Peter D, Linke Katrin, Feltham Rebecca, Schumacher Frances-Rose, Smith Clyde A, Vaux David L, Silke John, Day Catherine L
Biochemistry Department, University of Otago, Dunedin 9054, New Zealand.
J Biol Chem. 2008 Nov 14;283(46):31633-40. doi: 10.1074/jbc.M804753200. Epub 2008 Sep 10.
Inhibitor of apoptosis (IAP) proteins are key negative regulators of cell death that are highly expressed in many cancers. Cell death caused by antagonists that bind to IAP proteins is associated with their ubiquitylation and degradation. The RING domain at the C terminus of IAP proteins is pivotal. Here we report the crystal structures of the cIAP2 RING domain homodimer alone, and bound to the ubiquitin-conjugating (E2) enzyme UbcH5b. These structures show that small changes in the RING domain accompany E2 binding. By mutating residues at the E2-binding surface, we show that autoubiquitylation is required for regulation of IAP abundance. Dimer formation is also critical, and mutation of a single C-terminal residue abrogated dimer formation and E3 ligase activity was diminished. We further demonstrate that disruption of E2 binding, or dimerization, stabilizes IAP proteins against IAP antagonists in vivo.
凋亡抑制蛋白(IAP)是细胞死亡的关键负调控因子,在许多癌症中高表达。与IAP蛋白结合的拮抗剂所引起的细胞死亡与其泛素化和降解有关。IAP蛋白C末端的RING结构域至关重要。在此,我们报告了单独的cIAP2 RING结构域同二聚体以及与泛素结合(E2)酶UbcH5b结合的晶体结构。这些结构表明,RING结构域在与E2结合时会发生微小变化。通过突变E2结合表面的残基,我们表明自泛素化是调节IAP丰度所必需的。二聚体形成也很关键,单个C末端残基的突变消除了二聚体形成,E3连接酶活性降低。我们进一步证明,E2结合或二聚化的破坏会在体内使IAP蛋白对IAP拮抗剂稳定。